Literature DB >> 11243541

Embolization for management of hepatic hemangiomas.

G S Deutsch1, K A Yeh, W B Bates, W B Tannehill.   

Abstract

Hemangiomas represent the most common primary tumor of the liver. Clinically the significance of these lesions is highly variable. The management of hemangiomas is controversial and is intimately related to the size, symptoms, and associated comorbidities of the patients who harbor these benign tumors. Series suggest that the vast majority of hemangiomas are less than 4 cm, asymptomatic, and clinically incidental findings. Symptomatic hemangiomas are large and associated with a constellation of vague upper abdominal complaints including pain, mass, distention, early satiety, and weight loss. A number of small series of surgically treated symptomatic hemangiomas have demonstrated enucleation as a safe and effective intervention. We report a collection of case reports using embolization as a primary treatment of symptomatic hemangiomas. The first patient is a 73-year-old black man previously treated for prostate cancer by radical prostatectomy and radiation. He developed weight loss, abdominal fullness, and early satiety. His symptoms were attributed to a large left lateral segmental liver mass that was biopsy proven to be a hemangioma. The second patient is a 49-year-old black women who complained of weakness, fatigue, night sweats, and anemia. The only abnormality discovered was a large right posterior hemangioma. The third patient is a 49-year-old black women with unexplained right upper quadrant pain and anemia who was found to have a 19 x 11 x 7.5-cm left hepatic hemangioma by CT. All three patients underwent elective treatment of their hemangiomas with highly selective hepatic embolization. There were no significant complications related to the procedures. Symptoms resolved for all patients acutely after treatment. The use of embolization for hepatic hemangiomas provides safe and effective treatment of the patient's symptoms while avoiding operative intervention, extended hospitalization, or postoperative recuperation. This treatment modality should be considered for the symptomatic hemangioma under elective conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243541

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Percutaneous microwave ablation for benign focal liver lesions: Initial clinical results.

Authors:  Zhigang Cheng; Ping Liang; Xiaoling Yu; Zhiyu Han; Fangyi Liu; Jie Yu; Xin Li
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

2.  Surgical management of giant hepatic hemangioma: A 10-year single center experience.

Authors:  Waad Farhat; Houssem Ammar; Mohamed Amine Said; Abdelkader Mizouni; Linda Ghabry; Eya Hammami; Rahul Gupta; Mohamed Ben Mabrouk; Ali Ben Ali
Journal:  Ann Med Surg (Lond)       Date:  2021-07-06

3.  Ultrasonography guided percutaneous radiofrequency ablation for hepatic cavernous hemangioma.

Authors:  Yan Cui; Li-Yan Zhou; Man-Ku Dong; Ping Wang; Min Ji; Xiao-Ou Li; Chang-Wei Chen; Zi-Pei Liu; Yong-Jie Xu; Hong-Wen Zhang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

4.  Management of liver hemangioma using trans-catheter arterial embolization.

Authors:  Kavous Firouznia; Hossein Ghanaati; Seyed Moayed Alavian; Mohssen Nassiri Toosi; Nasser Ebrahimi Daryani; Amir Hossein Jalali; Madjid Shakiba; Sima Hosseinverdi
Journal:  Hepat Mon       Date:  2014-12-25       Impact factor: 0.660

5.  A Nomogram Model for Predicting the Response to Transcatheter Arterial Embolization in Patients With Symptomatic Hepatic Hemangioma.

Authors:  Qinqin Liu; Nan You; Jiangqin Zhu; Jing Li; Ke Wu; Zheng Wang; Liang Wang; Yinan Zhu; Huiying Gu; Xuehui Peng; Lu Zheng
Journal:  Front Mol Biosci       Date:  2021-11-26

Review 6.  Enucleation versus hepatectomy for hepatic hemangiomas: A meta-analysis.

Authors:  Bin Jiang; Zheng-Chao Shen; Xiao-San Fang; Xiao-Ming Wang
Journal:  Front Surg       Date:  2022-07-28

7.  Surgical Treatment of Giant Liver Hemangioma Larger Than 10 cm: A Single Center's Experience With 86 Patients.

Authors:  Wei Zhang; Zhi-Yong Huang; Chang-Shu Ke; Chao Wu; Zhi-Wei Zhang; Bi-Xiang Zhang; Yi-Fa Chen; Wan-Guang Zhang; Peng Zhu; Xiao-Ping Chen
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.